Related Experiment Videos
Conversion to mucoidy in Pseudomonas aeruginosa
V Deretic1, D W Martin, M J Schurr
1Department of Microbiology, University of Texas Health Science Center, San Antonio 78284-7758.
Abstract:
Chronic respiratory complications in cystic fibrosis, compounded by recurring infections with mucoid Pseudomonas aeruginosa and the associated inflammation, are the primary cause of high mortality in this inheritable disease. Since the conversion of P. aeruginosa into the exopolysaccharide alginate overproducing strains plays a critical role in the establishment of chronic infection, studies are directed towards understanding the processes underlying this phenomenon. The genes (algU, mucA, and mucB) and genetic alterations responsible for conversion to mucoidy have been recently characterized. The mutations leading to the emergence of mucoid strains are superimposed on a regulatory system with elements that resemble those controlling other aspects of bacterial developmental physiology.
Insights
Chronic Pseudomonas aeruginosa infections in cystic fibrosis lead to mucoid strains, causing respiratory failure. Understanding the genetic basis of this mucoid conversion is key to developing new treatments for cystic fibrosis patients.
Area of Science:
- Microbiology
- Genetics
- Pulmonary Medicine
Background:
- Cystic fibrosis (CF) is a genetic disorder leading to chronic respiratory infections.
- Mucoid Pseudomonas aeruginosa strains are a major cause of morbidity and mortality in CF patients.
- Alginate overproduction by P. aeruginosa is critical for establishing chronic infections.
Purpose of the Study:
- To investigate the genetic mechanisms underlying the conversion of P. aeruginosa to mucoid strains.
- To understand the regulatory pathways involved in alginate overproduction.
Main Methods:
- Characterization of genes (algU, mucA, mucB) associated with mucoid conversion.
- Analysis of genetic alterations leading to mucoidy.
Main Results:
- Key genes (algU, mucA, mucB) and specific genetic alterations responsible for mucoid conversion have been identified.
- Mutations identified are part of a regulatory system similar to those in bacterial development.
Conclusions:
- Understanding the genetic basis of mucoid P. aeruginosa is crucial for combating chronic infections in cystic fibrosis.
- The identified regulatory system offers potential targets for therapeutic intervention.